Melanoma incidence in New Zealand and Australia are amongst the highest in the world. In New Zealand it is the third most common cancer in both males and females. With increasing awareness and early recognition of melanoma in conjunction with an ageing population, there is an increasing number of patients requiring melanoma surveillance. In this presentation, current models of care and recommendations for melanoma follow-up will be presented as well as discussions around the future directions of melanoma follow-up.